NasdaqCM - Delayed Quote USD

NEXGEL, Inc. (NXGL)

2.2100 -0.1200 (-5.15%)
At close: 4:00 PM EDT
2.2000 -0.01 (-0.45%)
After hours: 5:21 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Adam R. Levy CEO, President & Director 334.51k -- 1963
Mr. Adam E. Drapczuk III Chief Financial Officer 131.04k -- 1976
Mr. Gregory Robb Vice President of Operations -- -- --

NEXGEL, Inc.

2150 Cabot Boulevard West
Suite B
Langhorne, PA 19047
United States
215 702 8550 https://nexgel.com
Sector: 
Healthcare
Full Time Employees: 
19

Description

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Corporate Governance

NEXGEL, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Related Tickers